Why the Downside of Tariffs May Not Kill the Upside for US Steel Giants
24/7 Wall St. has tracked multiple stocks tied to steel and aluminum, and most of them saw impressive gains last week, and even into this week.
All Work
Chris Lange
How Target Missed the Mark in Q4
Target released disappointing fiscal fourth-quarter financial results before the markets opened on Tuesday.
Monday’s Biggest Winners and Losers in the S&P 500
Monday started out as a down day for the broad U.S. markets, but as it went on everything recovered and the markets found themselves posting an impressive gain on the day. At one point…
Does Deutsche Bank Finally Have It Right on Valeant?
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
Why Dermira Shares Are Getting Crushed
Dermira watched its shares absolutely collapse early on Monday after the firm reported disappointing results from its late-stage trials in patients with acne vulgaris.
Why Clearside BioMedical Is Monday’s Biggest Winner
Clearside BioMedical saw its shares make an incredible gain to start the week after the firm announced positive topline results from its late-stage trial.
Lyft Looks to Pioneer the Future of Ride-Hailing
In a groundbreaking move early on Monday, the ride-hailing service Lyft is partnering with Allscripts Health Solutions to help hospitals and doctors’ offices schedule rides for patients who need them.
How Walmart Is Breaking Into Meal Kits
Walmart is taking a shot at meal kit providers like Blue Apron by offering meal kits and simpler “one-step meals” in over 250 stores.
Target, Costco and More Big Earnings Coming This Week
24/7 Wall St. has put together a preview of Target, Costco, Kroger and some of the other top companies reporting their latest results in the coming week.
Salesforce.com: Why Analysts and Investors Can’t Get Enough
The most recent earnings report only seems to prove that analysts and investors cannot get enough of Salesforce.com.
Major Biopharma Catalysts and FDA Events to Look For in March
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Friday’s Biggest Winners and Losers in the S&P 500
Friday started out as another bad day for the broad U.S. markets, but as it went on, everything seemed to turn around but not entirely. At one point the Dow was down 400 points,…
Dick’s Down as Sports Retail Disappoints
Dick’s Sporting Goods has been upfront in the news this week, after the company very publicly announced that it will halt sales of all assault-style and semi-automatic rifles.
Are Investors Getting Enough From the Microsemi Acquisition?
Shares of Microsemi saw a handy gain to close out the week after it was announced that the company would be acquired by Microchip Technology.
If You Invested $1000 in Goldman Sachs at the Market Bottom, Now It Would Be Worth $3500
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Goldman Sachs?
Can Sprint Change Its Luck With Half-Priced iPhone Xs?
The big four U.S. telecoms have been waging a war for dominance in the field for quite some time, and now Sprint is pulling out the big guns.
If You Invested $1000 in Intel at the Market Bottom, Now It Would Be Worth $5150
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Intel?
If You Invested $1000 in Verizon at the Market Bottom, Now It Would Be Worth $2900
The S&P 500 has more than quadrupled since its bottom nearly nine years ago. So how does this stack up against Verizon?
Are Investors Overreacting to Foot Locker Earnings?
Foot Locker released its fourth-quarter financial results before the markets opened on Friday, and investors have voted with their shares and sent the stock lower.
Why Gap Earnings (and Guidance) Are So Great
The Gap, Inc. (NYSE: GPS) released its fiscal fourth quarter financial results after the markets closed on Thursday. The company said that it had $0.61 in earnings per share (EPS) on $4.8 billion in…